Name Delivery Strategy Company Clinical Stage Disease Condition Used / Treated
Abraxane protein-bound particle Abraxis Bioscience [now Celgene] a approved metastatic breast cancer / NSCLC
NK 105 Polymeric micelle NanoCarrier phase III metastatic breast cancer / stomach cancer
CT-2103 Polymeric conjugate Cell Therapeutics phase III ovarian cancer
Genexol-PM Polymeric micelle Samyang phase III metastatic breast cancer
Tocosol emulsion Sonus Pharmaceuticals phase III / discontinued metastatic breast cancer
ANG 1005 peptide-bound conjugate Angiochem phase II glioma
EndoTag cationic liposome MediGene phase II metastatic breast cancer / pancreatic cancer
Paxceed Polymeric micelle Angiotech Pharmaceuticals phase II psoriasis
LEP-ETU liposome NeoPharm phase II metastatic breast cancer
OncoGel gel Protherics phase II esophageal cancer / primary brain cancer
PNU166945 Polymeric conjugate Pfizer phase I / discontinued
Table 4: Summary of PX-loaded NPs in Clinical Development.